During the past decade, Centro Especializado En Diabetes Y Metabolismo conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centro Especializado En Diabetes Y Metabolismo" are "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Centro Especializado En Diabetes Y Metabolismo" in a lesser frequency.

Most popular intervention types in "Centro Especializado En Diabetes Y Metabolismo" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centro Especializado En Diabetes Y Metabolismo" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Centro Especializado En Diabetes Y Metabolismo". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Centro Especializado En Diabetes Y Metabolismo, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centro Especializado En Diabetes Y Metabolismo, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".